Links for Friday

The last few days online:

• Lilly settles with Mississippi: $18.5 million — as Furious Seasons says, “That brings Lilly’s total settlements to date to around $2.8 billion and there’s still more to go.” Zyprexa is a deadly drug.
• ~
• Lilly: “Execute the *%#&*! out of them” The Carlat Psychiatry Blog —A new paper, written by Glen Spielmans and Peter Parry and published in the journal Bioethical Inquiry, shows how various drug companies, particularly Eli Lilly and AstraZeneca, manipulated science and lied to doctors in order to sell their drugs. While this is not exactly news, the intriguing aspect of this article is that the authors reproduce e-mails and slides that are the smoking guns of deceptive sales practices. And let me tell you, these gun barrels are hot and you can still smell the gun powder.
• ~
• Mindfulness and Pain, Part 2: Body Awareness — Urocyon — Ignoring and mistreating our bodies is encouraged a lot by our society. It’s way too easy to fall into treating your body like some sort of balky telepresence robot, for your mind to force into doing its bidding–sometimes to the breaking point. We are encouraged to ignore things like hunger signals, and push through injuries. Your body is not some kind of machine separate from the rest of you–and if you treat an actual piece of machinery like that, it will break down too!
• ~
• Growth from Suffering Fable — Traumatic events are “profoundly disturbing,” cause significant anxiety and stress, can give rise to “dysfunctional patterns of thinking,” including “repetitive intrusions of thoughts and images,” cause unpleasant, potentially significant physical reactions, and can cause or exacerbate psychiatric disorders. Said bluntly, traumatic events are bad. Posttraumatic Growth (PTG) is how adaptive personal development arises from the harsh circumstances of traumatic events. PTG is the consequence of “the struggle with in the aftermath of trauma.”
• ~
• Finding a better way to grieve : The New Yorker
• ~
• ‘Dr. Nobody’ Says 74% of Medical Schools Don’t Ban Ghostwriting | BNET Pharma Blog — Seventy-four percent of top medical schools have no policy prohibiting ghostwriting, according to a new study in Public Library of Science Medicine. The study was conducted by Dr. Jonathan Leo (top) and Jeffrey R. Lacasse, whom regular readers will remember were responsible for twisting JAMA into knots when they pointed out — correctly — that one of its authors had failed to disclose a conflict of interest with Forest Labs (FRX). A JAMA editor famously called Leo “a nobody and a nothing” for doing that.